Sinopsis
PeerCME is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerCME Publications, PeerCME is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Episodios
-
![Optimising Clinical Outcomes in Advanced EGFR-Mutant NSCLC]()
Optimising Clinical Outcomes in Advanced EGFR-Mutant NSCLC
08/07/2019 Duración: 20minOptimising Clinical Outcomes in Advanced EGFR-Mutant NSCLC
-
![Practice Challenges in NSCLC: Cases Clarifying First-Line Strategies for Advanced EGFR-Mutant Disease]()
Practice Challenges in NSCLC: Cases Clarifying First-Line Strategies for Advanced EGFR-Mutant Disease
27/03/2019 Duración: 21minPractice Challenges in NSCLC: Cases Clarifying First-Line Strategies for Advanced EGFR-Mutant Disease
-
![First-Line Options for Advanced EGFR-Mutant NSCLC: Applying Lessons From the Literature to Practice]()
First-Line Options for Advanced EGFR-Mutant NSCLC: Applying Lessons From the Literature to Practice
11/01/2019 Duración: 21minFirst-Line Options for Advanced EGFR-Mutant NSCLC: Applying Lessons From the Literature to Practice
-
![Update from the Experts: Novel Therapeutic Strategies and Best Practices in Management of FLT3-Mutated AML]()
Update from the Experts: Novel Therapeutic Strategies and Best Practices in Management of FLT3-Mutated AML
07/01/2019 Duración: 20minUpdate from the Experts: Novel Therapeutic Strategies and Best Practices in Management of FLT3-Mutated AML
-
![A Multidisciplinary Approach to Improving the Identification and Management of Patients With Transthyretin Amyloidosis]()
A Multidisciplinary Approach to Improving the Identification and Management of Patients With Transthyretin Amyloidosis
19/12/2018 Duración: 21minA Multidisciplinary Approach to Improving the Identification and Management of Patients With Transthyretin Amyloidosis
-
![EGFR-Mutant NSCLC: Evolving Treatment Paradigms and Game Changers for Current and Future Front-Line Care]()
EGFR-Mutant NSCLC: Evolving Treatment Paradigms and Game Changers for Current and Future Front-Line Care
31/10/2018 Duración: 01h13minEGFR-Mutant NSCLC: Evolving Treatment Paradigms and Game Changers for Current and Future Front-Line Care
-
![Maximising Overall Survival in Metastatic Castration-Resistant Prostate Cancer: An Aggressive Strategy to Optimising Treatment Sequencing]()
Maximising Overall Survival in Metastatic Castration-Resistant Prostate Cancer: An Aggressive Strategy to Optimising Treatment Sequencing
26/10/2018 Duración: 22minMaximising Overall Survival in Metastatic Castration-Resistant Prostate Cancer: An Aggressive Strategy to Optimising Treatment Sequencing
